3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Cisplatin
47
pembrolizumab
37
Magnetic Resonance Spectroscopy
33
Specimen Handling
26
Radiotherapy, Intensity-Modulated
21
Cetuximab
19
Carboplatin
18
Nivolumab
17
Platinum
16
1,2-diaminocyclohexaneplatinum II citrate
16
Radiotherapy
14
Biopsy
12
Paclitaxel
11
Radiation
10
Gemcitabine
10
Surveys and Questionnaires
9
Docetaxel
9
Taxes
7
Immunoglobulin G
7
Fluorouracil
7
Disulfides
7
cemiplimab
6
atezolizumab
6
Ipilimumab
6
Bevacizumab
6
toripalimab
5
Watchful Waiting
5
Immune Checkpoint Inhibitors
5
Drug Therapy
5
fludarabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radionuclide Imaging
×
Head & Neck
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled